Special Issue on: "Bio-Nano Materials and Drug Delivery Systems"
Dr. Priti Das, SCB Medical College and Hospital, India
The field of nanotechnology has become a pivotal point in electronics, biology and medicine. Its applications involve materials designed at atomic and molecular levels.
Nanoparticles are rapidly becoming the focus of many efforts aiming at targeted and site-specific drug delivery. The targeting ability of nanoparticles depends on factors such as particle size, surface charge, surface modification and hydrophobicity. Drug delivery systems have unusual material requirements which derive mainly from their therapeutic role: to administer drugs over prolonged periods of time at rates that are independent of patient-to-patient variables.
The chemical nature of the surfaces of such devices may stimulate biorejection processes, which can be enhanced or suppressed by the simultaneous presence of the drug that is being administered. Selection of materials for such systems is further complicated by the need for compatibility with the drug contained within the system.
Many problems related to selective binding, targeted delivery and toxicity still need to be overcome. Limited knowledge about the toxicity of nanoparticles is a major concern and certainly deserves more attention. If these nanoparticles are cautiously designed to tackle problems related to target and route of administration, they may lead to a more successful paradigm in the world of therapeutics and research.
The most promising research in nanoparticle production is in the area of using supercritical fluids that are environmental friendly and free of toxic solvents. Much research is currently being performed to overcome these hurdles, and is likely to establish nanoparticle-based drug delivery as the golden standard for site-specific therapeutics.
Suitable topics include, but are not limited, to the following:
- Organic nanoparticles
- Inorganic nanoparticles
- 3D nanocomposites
- Therapeutic polymers
- Tissue engineering
- Nanofibrous scaffolds
- Novel nano-scale systems
- Nucleic acid delivery
- Target Delivery
- Drug Release Rate Control
- Selective binding
Notes for Prospective Authors
Submitted papers should not have been previously published nor be currently under consideration for publication elsewhere. (N.B. Conference papers may only be submitted if the paper has been completely re-written and if appropriate written permissions have been obtained from any copyright holders of the original paper).
All papers are refereed through a peer review process.
All papers must be submitted online. To submit a paper, please read our Submitting articles page.
Manuscripts due by: 31 January, 2018
Notification to authors: 31 March, 2018
Final versions due by: 31 May, 2018